Header Logo

Connection

GEORGE CHOLANKERIL to Risk Factors

Back to Details
This is a "connection" page, showing publications GEORGE CHOLANKERIL has written about Risk Factors.
GEORGE CHOLANKERIL
Connection Strength
1.117
Risk Factors
  1. The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults. J Pediatr Gastroenterol Nutr. 2024 07; 79(1):110-118.
    View in: PubMed
    Score: 0.075
  2. Reply to: "Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea". J Hepatol. 2024 05; 80(5):e218-e219.
    View in: PubMed
    Score: 0.074
  3. Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. J Hepatol. 2023 03; 78(3):493-500.
    View in: PubMed
    Score: 0.068
  4. Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Semin Liver Dis. 2023 02; 43(1):89-99.
    View in: PubMed
    Score: 0.068
  5. NAFLD and HCC: Time to Bridge the Gap. Hepatology. 2021 11; 74(5):2336-2338.
    View in: PubMed
    Score: 0.063
  6. Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation. Sci Rep. 2019 06 05; 9(1):8312.
    View in: PubMed
    Score: 0.054
  7. Inpatient Outcomes for Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention. J Clin Gastroenterol. 2019 02; 53(2):120-126.
    View in: PubMed
    Score: 0.053
  8. Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States. Transplantation. 2019 01; 103(1):131-139.
    View in: PubMed
    Score: 0.052
  9. Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States. J Gen Intern Med. 2018 09; 33(9):1423-1425.
    View in: PubMed
    Score: 0.051
  10. Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients. Transplantation. 2017 12; 101(12):e349.
    View in: PubMed
    Score: 0.049
  11. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Dig Dis Sci. 2017 10; 62(10):2915-2922.
    View in: PubMed
    Score: 0.047
  12. Skilled nursing facility placement in hospitalized elderly patients with colon cancer. Eur J Surg Oncol. 2016 Nov; 42(11):1660-1666.
    View in: PubMed
    Score: 0.044
  13. Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease. Liver Transpl. 2026 Jan 01; 32(1):86-94.
    View in: PubMed
    Score: 0.021
  14. Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome. Clin Gastroenterol Hepatol. 2025 Nov; 23(12):2232-2241.e10.
    View in: PubMed
    Score: 0.020
  15. Association of High-Sensitivity Troponins in Metabolic Dysfunction-Associated Steatotic Liver Disease With All-Cause and Cause-Specific Mortality. Aliment Pharmacol Ther. 2025 Jun; 61(11):1785-1793.
    View in: PubMed
    Score: 0.020
  16. Statin Use Is Associated With Protection Against Acute Cholangitis in Patients With Primary Sclerosing Cholangitis: A Multicenter Retrospective Cohort Study. Clin Transl Gastroenterol. 2025 Apr 01; 16(4):e00816.
    View in: PubMed
    Score: 0.020
  17. A Three Decade Analysis of Trends in Length of Stay After Liver Transplantation. Prog Transplant. 2025 06; 35(2):55-63.
    View in: PubMed
    Score: 0.020
  18. Is the Transplantation of Elderly and DCD Donors in Low MELD Recipients Justified: An Intent-to-treat Analysis. Transplantation. 2025 05 01; 109(5):823-831.
    View in: PubMed
    Score: 0.020
  19. Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality. J Gastroenterol Hepatol. 2024 Sep; 39(9):1950-1956.
    View in: PubMed
    Score: 0.019
  20. Steatotic liver disease-associated all-cause/cause-specific mortality in the United States. Aliment Pharmacol Ther. 2024 07; 60(1):33-42.
    View in: PubMed
    Score: 0.019
  21. Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver Int. 2023 10; 43(10):2198-2209.
    View in: PubMed
    Score: 0.018
  22. Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis. Eur J Surg Oncol. 2023 07; 49(7):1242-1249.
    View in: PubMed
    Score: 0.017
  23. Muscle strength in non-alcoholic fatty liver disease and all-cause and cause-specific mortality. Liver Int. 2023 02; 43(2):513-516.
    View in: PubMed
    Score: 0.017
  24. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality. Clin Gastroenterol Hepatol. 2023 04; 21(4):940-948.e2.
    View in: PubMed
    Score: 0.017
  25. Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis. J Addict Med. 2022 Jul-Aug 01; 16(4):e248-e256.
    View in: PubMed
    Score: 0.016
  26. Elevated serum sodium in recipients of liver transplantation has a substantial impact on outcomes. Transpl Int. 2021 Oct; 34(10):1971-1983.
    View in: PubMed
    Score: 0.016
  27. Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease. Hepatology. 2020 11; 72(5):1556-1568.
    View in: PubMed
    Score: 0.015
  28. Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA. Dig Dis Sci. 2021 05; 66(5):1461-1476.
    View in: PubMed
    Score: 0.014
  29. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017. Gastroenterology. 2019 10; 157(4):1055-1066.e11.
    View in: PubMed
    Score: 0.014
  30. Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers. Ann Hepatol. 2019 Sep - Oct; 18(5):679-684.
    View in: PubMed
    Score: 0.013
  31. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis. Liver Transpl. 2019 03; 25(3):399-410.
    View in: PubMed
    Score: 0.013
  32. Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2019 02; 31(2):149-156.
    View in: PubMed
    Score: 0.013
  33. Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis. Hepatol Int. 2019 Jan; 13(1):84-90.
    View in: PubMed
    Score: 0.013
  34. Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. Clin Gastroenterol Hepatol. 2019 10; 17(11):2379-2381.
    View in: PubMed
    Score: 0.013
  35. Early Liver Transplantation is a Viable Treatment Option in Severe Acute Alcoholic Hepatitis. Alcohol Alcohol. 2018 Nov 01; 53(6):716-718.
    View in: PubMed
    Score: 0.013
  36. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016. Gastroenterology. 2018 10; 155(4):1154-1163.e3.
    View in: PubMed
    Score: 0.013
  37. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. Dig Dis Sci. 2018 Jun; 63(6):1647-1653.
    View in: PubMed
    Score: 0.012
  38. Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis. Nutrients. 2017 Oct 13; 9(10).
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.